Early Access — free while we kick the tires
EdgarHawk

Kendall Brandi

See remarks

Director Officer
2 filings analyzed · 1 company · Latest 2025-03-19

Never miss a filing from Kendall Brandi

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Crescent Energy Co CRGY 2 0 Net buying

Activity

March 2025
2025-03-19 Crescent Energy Co CRGY
medium
Buy
932 shares
$10,299
Significance 6/10

Kendall Brandi bought 932 CRGY shares at $11.05; stock down 21.2% in 30 days as company remains unprofitable despite 23.0% annual revenue growth.

Kendall Brandi purchased 932 shares at $11.05, increasing holdings to 23,347 shares (+4.2%), while the stock has fallen 21.2% over the past 30 days and trades at $11.72, down 30.0% from its 52-week high of $16.74. Notably, of Brandi's 5 prior purchases at CRGY, 3 were followed by positive 90-day returns, suggesting a pattern of reasonable timing at this ticker. However, the timing context here is less favorable: the stock is in a sharp decline, and Crescent Energy reported a negative net income of $-9.9M in its latest quarter despite posting $744.9M in revenue and achieving 23.0% annual revenue growth. The unprofitability combined with recent sharp price weakness means this purchase occurs as momentum deteriorates, even though the insider's historical track record at this specific ticker shows mixed but partly successful calls.

September 2024
2024-09-09 Crescent Energy Co CRGY
medium
Buy
1,285 shares
$14,790
Significance 5/10

Kendall Brandi bought 1,285 shares of CRGY at $11.51 on 2024-09-05; stock down 24.7% from 52-week high, cluster of 3 other insider buys in past 14 days.

Kendall Brandi purchased 1,285 shares at $11.51, increasing holdings by 6.1% to 22,415 shares. The stock is currently trading at $10.37, down 24.7% from its 52-week high and 16.1% over the past 90 days. At CRGY specifically, Brandi's prior trades show mixed timing: 2 of 5 prior buys achieved positive 90-day returns, indicating inconsistent predictive value. The company's fundamentals show pressure, with annual revenue declining 22.1% year-over-year, though recent quarterly revenue was $653.3M and net income $37.5M. Notably, 3 other insiders bought within the past 14 days, forming a cluster pattern, though this does not conclusively signal confidence given the stock's sustained weakness and the company's deteriorating revenue trend.

Related insiders